John D. Carpten

30.0k citations

183 papers · 9.4k indexed · 4 hit papers · h-index 46

Molecular Biology top 1%
Genetics top 0.5%
Pulmonary and Respiratory Medicine top 1%
Cancer Research top 0.5%
Oncology top 1%

Co-authors: Jeffrey R. Smith Michael Brownstein David W. Craig Jeffrey M. Trent Sara A. Byron Christiane M. Robbins David M. Engelthaler Kendall Van Keuren‐Jensen
Topics: Prostate Cancer Treatment and Research (43 papers)Cancer Genomics and Diagnostics (41 papers)Multiple Myeloma Research and Treatments (20 papers)
Cited by: Cancer Research Hematology Nephrology
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United States Sweden United Kingdom

In The Last Decade

John D. Carpten

174 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modulation of Non-Templated Nucleotide Addition by Taq DNA Polymerase: Primer Modifications that Facilitate Genotyping

1996 1.1k citations John D. Carpten et al. profile →
Translating RNA sequencing into clinical diagnostics: opportunities and challenges

2016 504 citations Sara A. Byron, John D. Carpten et al. profile →
Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing

2012 474 citations John D. Carpten, David W. Craig et al. profile →
Clonal competition with alternating dominance in multiple myeloma

2012 456 citations Jonathan J. Keats, Marta Chesi et al. Blood profile →

Peers

Countries citing papers authored by John D. Carpten

Since Specialization

Citations

This map shows the geographic impact of John D. Carpten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Carpten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Carpten more than expected).

Fields of papers citing papers by John D. Carpten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Carpten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Carpten. The network helps show where John D. Carpten may publish in the future.

Co-authorship network of co-authors of John D. Carpten

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Carpten. A scholar is included among the top collaborators of John D. Carpten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Carpten. John D. Carpten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent 2023 ·Cell Death and Differentiation ·Arnold J. Levine,John D. Carpten,Maureen E. Murphy,Pierre Hainaut	3
2	The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors 2023 ·Cancers ·(unknown),(unknown),James L. Chen,Aakrosh Ratan,Martin D. McCarter,John D. Carpten,Howard Colman,Alexandra P. Ikeguchi,Igor Puzanov,Susanne M. Arnold,Michelle L. Churchman,Patrick Hwu,José R. Conejo-García,William S. Dalton,George J. Weiner,Issam El Naqa,Ahmad A. Tarhini	5
3	Alveolar type I cells can give rise to KRAS-induced lung adenocarcinoma 2023 ·Cell Reports ·(unknown),Hua Shen,Per Flodby,(unknown),Rania Bassiouni,Yixin Liu,Tea Jashashvili,(unknown),(unknown),Jonathan Castillo,Theresa Ryan Stueve,Daniel J. Mullen,Amy L. Ryan,John D. Carpten,Alessandra Castaldi,William D. Wallace,Beiyun Zhou,Zea Borok,Crystal N. Marconett	7
4	Incorporating long non-coding RNA (lncRNA) into genome-wide biomarker screening for prognostic gene signatures of immunotherapy outcomes. 2023 ·Journal of Clinical Oncology ·Xuefeng Wang,(unknown),Vineeth Sukrithan,Aakrosh Ratan,Martin D. McCarter,John D. Carpten,Howard Colman,Alexandra P. Ikeguchi,Igor Puzanov,Susanne M. Arnold,Michelle L. Churchman,Patrick Hwu,William S. Dalton,George J. Weiner,Ahmad A. Tarhini	2
5	Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer 2022 ·Cancer Research ·Rania Bassiouni,Michael O. Idowu,Lee D. Gibbs,Valentina Robila,(unknown),(unknown),(unknown),(unknown),David W. Craig,John D. Carpten	46
6	Applicability of spatial transcriptional profiling to cancer research 2021 ·Molecular Cell ·Rania Bassiouni,Lee D. Gibbs,David W. Craig,John D. Carpten,Troy A. McEachron	38
7	Cancer transcriptomic profiling from rapidly enriched circulating tumor cells 2020 ·International Journal of Cancer ·(unknown),(unknown),(unknown),Yucheng Xu,(unknown),Eric S. C. Kwok,(unknown),Tanya B. Dorff,David I. Quinn,John D. Carpten,Zarko Manojlovic,Amir Goldkorn	8
8	A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy 2017 ·PLoS ONE ·Glen J. Weiss,Sara A. Byron,Jessica Aldrich,Ashish Sangal,(unknown),Jeffrey Kiefer,John D. Carpten,David W. Craig,Timothy G. Whitsett	8
9	Identifying aggressive prostate cancer foci using a DNA methylation classifier 2017 ·Genome biology ·Kamilla Mundbjerg,Sameer Chopra,Mehrdad Alemozaffar,Christopher E. Duymich,Ranjani Lakshminarasimhan,Peter W. Nichols,Manju Aron,Kimberly D. Siegmund,Osamu Ukimura,Monish Aron,Mariana C. Stern,Parkash S. Gill,John D. Carpten,Torben F. Ørntoft,Karina D. Sørensen,Daniel J. Weisenberger,Peter A. Jones,Vinay Duddalwar,Inderbir S. Gill,Gangning Liang	43
10	CUL3 and NRF2 Mutations Confer an NRF2 Activation Phenotype in a Sporadic Form of Papillary Renal Cell Carcinoma 2013 ·Cancer Research ·Aikseng Ooi,Karl Dykema,Asif Ansari,David Petillo,John Snider,Richard J. Kahnoski,John Anema,David W. Craig,John D. Carpten,Bin Tean Teh,Kyle A. Furge	121
11	Clonal competition with alternating dominance in multiple myelomabreakdown → 2012 ·Blood ·Jonathan J. Keats,Marta Chesi,Jan B. Egan,Victoria M. Garbitt,Stephen Palmer,Esteban Braggio,Scott Van Wier,Patrick R. Blackburn,Angela Baker,Angela Dispenzieri,Shaji Kumar,S. Vincent Rajkumar,John D. Carpten,Michael T. Barrett,Rafaël Fonseca,A. Keith Stewart,P. Leif Bergsagel	456
12	Advancing a clinically relevant perspective of the clonal nature of cancer 2011 ·Proceedings of the National Academy of Sciences ·Christian Ruiz,Elizabeth Lenkiewicz,Lisa Evers,Tara Holley,(unknown),Jeffrey Kiefer,Michael J. Demeure,Michael A. Hollingsworth,(unknown),Donna Prunkard,Peter S. Rabinovitch,Tobias Zellweger,Spyro Mousses,Jeffrey M. Trent,John D. Carpten,Lukas Bubendorf,Daniel D. Von Hoff,Michael T. Barrett	90
13	Racial Disparities in Prostate Cancer Incidence, Biochemical Recurrence, and Mortality 2011 ·SHILAP Revista de lepidopterología ·Cathryn H. Bock,Isaac J. Powell,Rick A. Kittles,Ann W. Hsing,John D. Carpten	14
14	DNA Methylation Analysis Determines the High Frequency of Genic Hypomethylation and Low Frequency of Hypermethylation Events in Plasma Cell Tumors 2010 ·Cancer Research ·Bodour Salhia,Angela Baker,Gregory Ahmann,Daniel Auclair,Rafaël Fonseca,John D. Carpten	42
15	A Novel Prostate Cancer Susceptibility Locus at 19q13 2009 ·Cancer Research ·Fang‐Chi Hsu,Jielin Sun,Fredrik Wiklund,Sarah D. Isaacs,Kathleen E. Wiley,Lina D. Purcell,Zhengrong Gao,Pär Stattin,Yi Zhu,Seong‐Tae Kim,Zheng Zhang,Wennuan Liu,Bao-Li Chang,Patrick C. Walsh,David Duggan,John D. Carpten,William B. Isaacs,Henrik Grönberg,Jianfeng Xu,S. Lilly Zheng	36
16	Association of a Germ-Line Copy Number Variation at 2p24.3 and Risk for Aggressive Prostate Cancer 2009 ·Cancer Research ·Wennuan Liu,Jishan Sun,Ge Li,Yi Zhu,(unknown),Seong‐Tae Kim,Jielin Sun,Fredrik Wiklund,Kathleen E. Wiley,Sarah D. Isaacs,Pär Stattin,Jianfeng Xu,David Duggan,John D. Carpten,William B. Isaacs,Henrik Grönberg,S. Lilly Zheng,Bao-Li Chang	58
17	Sequence Variants at 22q13 Are Associated with Prostate Cancer Risk 2008 ·Cancer Research ·Jielin Sun,Siqun L. Zheng,Fredrik Wiklund,Sarah D. Isaacs,Ge Li,Kathleen E. Wiley,Seong‐Tae Kim,Yi Zhu,Zheng Zhang,Fang‐Chi Hsu,Aubrey R. Turner,Pär Stattin,Wennuan Liu,Jin Woo Kim,David Duggan,John D. Carpten,William B. Isaacs,Henrik Grönberg,Jianfeng Xu,Bao‐Li Chang	79
18	Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling 2007 ·Cancer Research ·Wee Joo Chng,Shaji Kumar,Scott VanWier,Greg Ahmann,Tammy Price-Troska,(unknown),Tae‐Hoon Chung,Seungchan Kim,George Mulligan,Barbara M. Bryant,John D. Carpten,Morie A. Gertz,S. Vincent Rajkumar,Martha Q. Lacy,Angela Dispenzieri,Robert A. Kyle,Philip R. Greipp,P. Leif Bergsagel,Rafaël Fonseca	195
19	The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth 2005 ·Journal of Clinical Investigation ·David K. Rhee,José Roberto Marcelino,(unknown),(unknown),Patrick Smits,Véronique Lefebvre,Gregory D. Jay,Matthew C. Stewart,Hongwei Wang,Matthew L. Warman,John D. Carpten	404
20	Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees 2001 ·Journal of Lipid Research ·Mi‐Hye Lee,Starr Hazard,John D. Carpten,(unknown),Jonathan C. Cohen,(unknown),Gerald Salen,Shailendra B. Patel	56

About John D. Carpten

John D. Carpten is a scholar working on Cancer Research, Hematology and Genetics, having authored 183 papers that have together received 9.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (43 papers), Cancer Genomics and Diagnostics (41 papers) and Multiple Myeloma Research and Treatments (20 papers). The work is most often cited by research in Cancer Research (2.1k citations), Hematology (1.1k citations) and Nephrology (578 citations). John D. Carpten has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Jeffrey R. Smith, Michael Brownstein, David W. Craig, Jeffrey M. Trent, Sara A. Byron, Christiane M. Robbins, David M. Engelthaler, Kendall Van Keuren‐Jensen, Rafaël Fonseca and Gregory D. Jay. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact